Report #2837054

Received Apr 21, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Female
Age: Age unknown
State: IL
Recovered: Unknown
Vaccinated: Jan 1, 2025
Onset: Jan 1, 2025
Days to onset: 0
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
MNQ	MENINGOCOCCAL CONJUGATE (MENVEO)	NOVARTIS VACCINES AND DIAGNOSTICS	UNK	AMA8030A	—

Symptoms (1)

Product preparation issue

Symptom narrative

Menveo after only the diluent portion; Menveo after only the diluent portion; This non-serious case was reported by a nurse via call center representative and described the occurrence of inappropriate preparation of medication in a 12-year-old female patient who received Men ACWY-CRM NVS (Menveo) (batch number AMA8030A, expiry date 30-APR-2025) for prophylaxis. In JAN-2025, the patient received Menveo. In JAN-2025, an unknown time after receiving Menveo, the patient experienced inappropriate preparation of medication (Verbatim: Menveo after only the diluent portion) and inappropriate dose of vaccine administered (Verbatim: Menveo after only the diluent portion). The outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were not applicable. Additional Information: GSK Receipt Date: 14-APR-2025 The nurse reported that how to proceed and the validity of a dose of Menveo after only the diluent portion, which led to inappropriate preparation of medication and inappropriate dose of vaccine administered. The vaccine administration facility was the same as primary reporter.